WE ARE COMMITTED TO PATIENTS
David and Goliath Pharma is a privately owned company licensed to operate across the value chain of medical cannabis, from strain enhancement, through cultivation, production, and distribution. At the core of what we do is our commitment to patients, ensuring they get high quality and non-interrupted medical cannabis supply. Our teams have extensive experience of Dozens years in the pharmaceuticals and medical cannabis sector.
Since we want to oversee and control the entire process of growing, producing, and distributing medical-grade cannabis-based products, we carry out the entire cannabis breeding process. we implement a variety of measures and work according to strict protocols in order to grow high-quality strains, especially with identical components, in all growth cycles.
All growth process are undertaken in order to deliver a product that is grown, processed, and shipped while Preserve its original qualities
In the industrial area of the Be’er Tuvia Regional Council in southern Israel, we’ve established a state-of-the-art facility in strict compliance with the Israeli IMC-GMP standard and the EU-GMP European standard. We extract cannabis inflorescence for medical use utilizing innovative technology, which enables the production of advanced cannabis products composed of precise amounts of active ingredients. All processes and machinery in the facility are designed, produced, and operated in order to properly maintain the quantity and quality of the active ingredients in the cannabis plant.
We are committed to ongoing research in order to improve the quality of care and assist the sick through the use of medical-grade cannabis.
David and Goliath partner in cutting-edge research, some already in its advanced stages, in order to improve the quality of medical cannabis treatment, as well as to tailor treatment to each patient according to their needs. Our main focus is To break one of the biggest barriers for medical cannabis which is consumption forms and their efficacy; Our R&D, in collaboration with third parties experts working on additional forms of intake